Clinical Trial

Programmed Cell Death Ligand 1 PET/CT in Various PD-L1-Related Disease Patients

Recruiting
View on ClinicalTrials.gov →
Summary
To evaluate the potential usefulness of 68Ga/18F-PD-L1 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various PD-L1-related disease patients
Trial Details
NCT Number NCT07618936
Lead Sponsor Tianjin Medical University
Collaborators: Tianjin Medical University General Hospital
Conditions PD-L1 Gene Mutation, PD-L1 Gene Amplification, PD-L1-related Disease, Positron Emission Tomography
Enrollment 500 participants
Start Date 2026-06-01
Primary Completion 2031-06-01 (estimated)
Study Completion 2031-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-01